Logo-jcvtr

J Cardiovasc Thorac Res. 2018;10(1): 46-52. doi: 10.15171/jcvtr.2018.08
PMID: 29707178        PMCID: PMC5913693

Original Article

CHA2DS2-VASc Score Predict No-Reflow Phenomenon in Primary Percutaneous Coronary Intervention in Primary Percutaneous Coronary Intervention

Fardin Mirbolouk 1, Mahboobeh Gholipour 1, Arsalan Salari 1, Maryam Shakiba 2, Jalal kheyrkhah 1, Vahid Nikseresht 3, Nozar Sotoudeh 4 * , Negar Moghadam 4, Mohammad Jaafar Mirbolouk 4, Mani Moayeri far 4

Cited by CrossRef: 23

1- Somuncu M, Akgun T, Cakır M, Akgul F, Serbest N, Karakurt H, Can M, Demir A. The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. JAT. 2019;26(11):970 [Crossref]
2- Abacioglu O, Yildirim A, Koyunsever N, Kilic S. The ATRIA and Modified-ATRIA Scores in Evaluating the Risk of No-Reflow in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention. Angiology. 2022;73(1):79 [Crossref]
3- Bamarinejad F, Kermani-alghoraishi M, Soleimani A, Roohafza H, Yazdekhasti S, Azarm M, Bamarinejad A, Sadeghi M. Clinical, laboratory, and procedural predictors of slow flow/no reflow phenomenon after emergency percutaneous coronary interventions in ST-elevated myocardial infarction. Egypt Heart J. 2024;76(1) [Crossref]
4- Ashoori A, Pourhosseini H, Ghodsi S, Salarifar M, Nematipour E, Alidoosti M, Haji-Zeinali A, Nozari Y, Amirzadegan A, Aghajani H, Jalali A, Hosseini Z, Jenab Y, Geraiely B, Omidi N. CHA2DS2-VASc Score as an Independent Predictor of Suboptimal Reperfusion and Short-Term Mortality after Primary PCI in Patients with Acute ST Segment Elevation Myocardial Infarction. Medicina. 2019;55(2):35 [Crossref]
5- Wang X, Pei C, Bai Y, Dai Q, Deng X, Liu Y, Li Z, You J, Peng J, Lin L, Zou Y. Predictive Value of CHA2DS2-VASc Score for Ischemic Events in Patients Undergoing Percutaneous Coronary Intervention. Angiology. 2019;70(9):878 [Crossref]
6- Zhang Q, Ma S, Sun J. New CHA2DS2-VASc-HSF score predicts the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. BMC Cardiovasc Disord. 2020;20(1) [Crossref]
7- Cozac D, Lakatos E, Demjen Z, Ceamburu A, Fișcă P, Șuș I, Hadadi L, Scridon A. The CHA2DS2-VASc Score Predicts New-Onset Atrial Fibrillation and Hemodynamic Complications in Patients with ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention. Diagnostics. 2022;12(10):2396 [Crossref]
8- Hadadi M, Mohseni-Badalabadi R, Hosseinsabet A. Assessment of the ability of the CHA2DS2-VASc scoring system to grade left atrial function by 2D speckle-tracking echocardiography. BMC Cardiovasc Disord. 2021;21(1) [Crossref]
9- Agudelo V, Millán X, Li C, Asmarats L, Fernández-Peregrina E, Santaló M, Jimenez-Kockar M, Gheorghe L, Serra A, Arzamendi D. Impact of the CHA2DS2-VASc score on late clinical outcomes in patients undergoing left atrial appendage occlusion. International Journal of Cardiology. 2020;319:78 [Crossref]
10- Bayam E, Çakmak E, Yıldırım E, Kalçık M, Bilen Y, Güner A, Küp A, Kahyaoğlu M, Çelik M, Öcal L, Avcı A, Zehir R. The relationship between CHA2DS2VASc score and left ventricular apical thrombus formation in patients with acute anterior ST segment elevation myocardial infarction. Acta Cardiologica. 2023;78(1):24 [Crossref]
11- Cheng C, Liu X, Bi S, Lu Q, Zhang J, den Uil C. Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction. PLoS ONE. 2019;14(8):e0220654 [Crossref]
12- Abd El-Moneum M. Evaluation of the predictive value of CHA2DS2-VASc Score for no-reflow phenomenon in patients with ST-segment elevation myocardial infarction who underwent Primary Percutaneous Coronary Intervention. J Cardiol Cardiovasc. 2019;4(3):171 [Crossref]
13- Kumar R, Ammar A, Saghir T, Sial J, Khan K, Shah J, Shaikh A, Rizvi S, Qamar N, Karim M. Development and Validation of a Novel Risk Stratification Model for Slow-Flow/No-Reflow During Primary Percutaneous Coronary Intervention (the RK-SF/NR Score). The American Journal of Cardiology. 2022;171:32 [Crossref]
14- Harbalıoğlu H, Genç Ö, Alıcı G, Quisi A, Yıldırım A. Impact of HAT2CH2 Score on the Development of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction. Angiology. 2024;75(1):44 [Crossref]
15- Dawson L, Rashid M, Dinh D, Brennan A, Bloom J, Biswas S, Lefkovits J, Shaw J, Chan W, Clark D, Oqueli E, Hiew C, Freeman M, Taylor A, Reid C, Ajani A, Kaye D, Mamas M, Stub D. No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score. Circ: Cardiovascular Interventions. 2024;17(4) [Crossref]
16- Altunova M, Koseoglu M. A Novel Marker Triglyceride Glucose Index in Predicting the Development of No-reflow in Acute Coronary Syndrome without ST-segment Elevation. Haseki. 2024;62(1):1 [Crossref]
17- Liu Y, Dai Y, Wang L, Chen P, Zeng L, Zhang Y, Duan C, Chen J, Tan N, He P. Association between DBP and major adverse cardiovascular events in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. 2022;40(4):692 [Crossref]
18- Wu G, Wu Z, Xu B, Chen S, Su W, Liu Y, Wu T, Shen Q, Zong G. Slow-Reflow and Prognosis in Patients with High Parathyroid Hormone Levels Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction. J of Cardiovasc Trans Res. 2024;17(3):657 [Crossref]
19- Mahfouz R, Gad M, Arab M, Abulfotouh M. Presence of Microvascular Dysfunction and CHA2DS2-VASc Score in Patients with ST-Segment Myocardial Infarction after Primary Percutaneous Coronary Intervention. Pulse. 2021;9(3-4):125 [Crossref]
20- Rashed M, Saleh M, Elfekky E, Elmahmoudy A. CHA2DS2 VASc score and brachial artery flow-mediated dilation as predictors for no-reflow phenomenon in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Egypt Heart J. 2022;74(1) [Crossref]
21- Sazanov G, Shugushev Z, Belokon O, Ermakov S, Khripunova A. Dilation of the Infarct-Related Coronary Artery to Reduce the Incidence of the No-Reflow Phenomenon in STEMI Patients. Innovacionnaâ medicina Kubani. 2023;(3):54 [Crossref]
22- Maden O, Çakmak Karaaslan Ö, Kanal Y, Yakut İ, Yaman N, Könte H, Balcı K, Selçuk M, Selçuk H. Association of CHA2DS2-VASc score with thrombus burden in patients with acute myocardial infarction undergoing SVG-PCI. Herz. 2022;47(5):456 [Crossref]
23- Kanal Y, Balci K, Yaman N, Yakut Í, Ozbay M, Maden O. The Relationship between CHA2DS2-VASc Score and Reperfusion Success in Elective Percutaneous Saphenous Vein Graft Interventions. 2023;36 [Crossref]
24- Barman H, Kahyaoglu S, Durmaz E, Atici A, Gulsen K, Tugrul S, Isleyen H, Yildirim M, Gungor B, Okuyan E, Sahin I. The CHADS-VASc score is a predictor of no-reflow in patients with non-ST-segment elevation myocardial infarction. 2020;31(1):7 [Crossref]
25- Huang X, Zheng W, Zhao X, Nie S. CHA2DS2-VASc score predicts the slow flow/no-reflow phenomenon in ST-segment elevation myocardial infarction patients with multivessel disease undergoing primary percutaneous coronary intervention. 2021;100(21):e26162 [Crossref]
26- Sanlialp S, Sanlialp M, Guler S. CHA2DS2-VASc-HSF Score may Better Predict the Development of Total Coronary Artery Occlusion in Acute Coronary Syndrome. Angiology. 2022;73(4):387 [Crossref]
27- Shaikh A, Kumar R, Ammar A, Hussain A, Mengal M, Khan K, Qayyum D, Sial J, Saghir T, Karim M. CHA2 DS2 -VASc score, a simple clinical tool for early prediction of no-reflow phenomenon in patients undergoing emergency percutaneous coronary revascularization. J Cardiovasc Thorac Res. 2022;14(2):122 [Crossref]
28- Song H, Chu Y, Dong S, Yu H, Cui S. Relationship between thrombolysis in myocardial infarction blood flow before percutaneous coronary intervention and the morphological characteristics of culprit vessel plaques in patients with STEMI. Exp Ther Med. 2023;26(6) [Crossref]